ARTICLE | Company News
Biotecnol Inc., Chiome deal
February 4, 2013 8:00 AM UTC
The companies partnered to co-develop multi-specific Tribody molecules against undisclosed targets to treat cancer using Chiome's ADlib antibody generating system and Biotechnol's Tribody technology. ...